FMC Stock - FMC Corporation
Unlock GoAI Insights for FMC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.25B | $4.49B | $5.80B | $5.05B | $4.64B |
| Gross Profit | $1.58B | $1.91B | $2.39B | $2.19B | $2.07B |
| Gross Margin | 37.1% | 42.5% | 41.1% | 43.3% | 44.5% |
| Operating Income | $654.70M | $837.90M | $1.29B | $1.17B | $1.12B |
| Net Income | $339.90M | $1.32B | $736.50M | $739.60M | $552.40M |
| Net Margin | 8.0% | 29.4% | 12.7% | 14.7% | 11.9% |
| EPS | $2.73 | $10.51 | $5.83 | $5.75 | $4.24 |
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that include insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. FMC Corporation was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 9th 2025 | Barclays | Downgrade | Underweight | $13 |
| November 11th 2025 | Wells Fargo | Resumed | Equal Weight | $16 |
| October 31st 2025 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
| October 31st 2025 | Wells Fargo | Downgrade | Equal Weight | $16 |
| October 30th 2025 | Barclays | Downgrade | Equal Weight | $22 |
| October 14th 2025 | BofA Securities | Upgrade | Neutral | $33 |
| June 23rd 2025 | Wells Fargo | Upgrade | Overweight | $50 |
| April 25th 2025 | Mizuho | Upgrade | Outperform | $49 |
| March 13th 2025 | Goldman | Initiation | Buy | $51 |
| February 14th 2025 | Redburn Atlantic | Downgrade | Neutral | $49 |
| February 7th 2025 | UBS | Downgrade | Neutral | $38← $66 |
| February 5th 2025 | RBC Capital Mkts | Downgrade | Sector Perform | $47← $78 |
| January 21st 2025 | Barclays | Upgrade | Overweight | $65 |
| January 14th 2025 | BofA Securities | Upgrade | Neutral | $61← $63 |
| October 23rd 2024 | Citigroup | Initiation | Neutral | $67 |
Earnings History & Surprises
FMCEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 3, 2026 | $1.23 | — | — | — |
Q4 2025 | Oct 29, 2025 | $0.85 | $0.89 | +4.7% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.59 | $0.69 | +16.9% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $0.08 | $0.18 | +125.0% | ✓ BEAT |
Q1 2025 | Feb 4, 2025 | $1.65 | $1.79 | +8.5% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $0.49 | $0.69 | +40.8% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $0.50 | $0.63 | +26.0% | ✓ BEAT |
Q2 2024 | May 6, 2024 | $0.35 | $0.36 | +2.9% | ✓ BEAT |
Q1 2024 | Feb 5, 2024 | $1.09 | $1.07 | -1.8% | ✗ MISS |
Q4 2023 | Oct 30, 2023 | $0.45 | $0.44 | -2.2% | ✗ MISS |
Q3 2023 | Aug 2, 2023 | $0.59 | $0.50 | -15.3% | ✗ MISS |
Q2 2023 | May 1, 2023 | $1.75 | $1.77 | +1.1% | ✓ BEAT |
Q1 2023 | Feb 7, 2023 | $2.33 | $2.37 | +1.7% | ✓ BEAT |
Q4 2022 | Nov 1, 2022 | $1.12 | $1.23 | +9.8% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $1.90 | $1.93 | +1.6% | ✓ BEAT |
Q2 2022 | May 2, 2022 | $1.71 | $1.88 | +9.9% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $2.02 | $2.16 | +6.9% | ✓ BEAT |
Q4 2021 | Nov 2, 2021 | $1.32 | $1.43 | +8.3% | ✓ BEAT |
Q3 2021 | Aug 3, 2021 | $1.78 | $1.81 | +1.7% | ✓ BEAT |
Latest News
Mizuho Maintains Outperform on FMC, Lowers Price Target to $24
📈 PositiveFMC Announces Manufacturing Restructuring Program, Sees Pre-Tax Restructuring Charges $560M-$635M, Sees $175M Of Annual Run-Rate Savings By End Of 2027
➖ NeutralJP Morgan Maintains Neutral on FMC, Lowers Price Target to $14
➖ NeutralMorgan Stanley Maintains Equal-Weight on FMC, Lowers Price Target to $17
📉 NegativeGoldman Sachs Maintains Buy on FMC, Lowers Price Target to $19
➖ NeutralWells Fargo Downgrades FMC to Equal-Weight, Lowers Price Target to $16
📉 NegativeFMC extends drop to multiyear lows after two more analyst downgrades
📉 NegativeUBS Maintains Neutral on FMC, Lowers Price Target to $17
➖ NeutralRBC Capital Maintains Sector Perform on FMC, Lowers Price Target to $17
➖ NeutralKeybanc Downgrades FMC to Sector Weight
📉 NegativeFMC shares are trading lower after the company lowered its FY2025 earnings and sales guidance.
📉 NegativeFMC President Ronaldo Pereira To Step Down, Effective Dec. 15
📉 NegativeFMC Sees Q4 Adj EPS $1.14-$1.36 vs $1.76 Est; Sees Sales $1.120B-$1.220B vs $1.296B Est
📉 NegativeFMC Lowers FY2025 Adj EPS Guidance from $3.26-$3.70 to $2.92-$3.14 vs $3.50 Est; Lowers FY2025 Sales Guidance from $4.080B-$4.280B to $3.920B-$4.020B vs $4.192B Est
📉 NegativeFMC Q3 Adj. EPS $0.89 Beats $0.86 Estimate, Sales $542.200M Miss $1.063B Estimate
📉 NegativeMorgan Stanley Maintains Equal-Weight on FMC, Lowers Price Target to $38
➖ NeutralGoldman Sachs Maintains Buy on FMC, Lowers Price Target to $43
➖ NeutralWells Fargo Maintains Overweight on FMC, Lowers Price Target to $41
➖ NeutralB of A Securities Upgrades FMC to Neutral, Lowers Price Target to $33
➖ NeutralMizuho Maintains Outperform on FMC, Lowers Price Target to $39
➖ NeutralFrequently Asked Questions about FMC
What is FMC's current stock price?
What is the analyst price target for FMC?
What sector is FMC Corporation in?
What is FMC's market cap?
Does FMC pay dividends?
Similar Stocks
Basic Materials SectorExplore stocks similar to FMC for comparison